These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10378123)

  • 61. Autoantibodies to oxidized low-density lipoprotein in patients with aortic regurgitation: association with aortic diameter size.
    Shimoni S; Bar I; Zilberman L; George J
    Cardiology; 2014; 128(1):54-61. PubMed ID: 24557059
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased low density lipoprotein oxidation in stable kidney transplant recipients.
    Ghanem H; van den Dorpel MA; Weimar W; Man in 'T Veld AJ; El-Kannishy MH; Jansen H
    Kidney Int; 1996 Feb; 49(2):488-93. PubMed ID: 8821834
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study.
    Ahmed E; Trifunovic J; Stegmayr B; Hallmans G; Lefvert AK
    Stroke; 1999 Dec; 30(12):2541-6. PubMed ID: 10582975
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evolution pattern of auto-antibodies against oxidized low-density lipoproteins in renal transplant recipients.
    Kandoussi AM; Glowacki F; Duriez P; Tacquet A; Fruchart JC; Noël C
    Nephron; 2001 Nov; 89(3):303-8. PubMed ID: 11598394
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls.
    van de Vijver LP; Steyger R; van Poppel G; Boer JM; Kruijssen DA; Seidell JC; Princen HM
    Atherosclerosis; 1996 May; 122(2):245-53. PubMed ID: 8769687
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B.
    Jansen H; Ghanem H; Kuypers JH; Birkenhäger JC
    Atherosclerosis; 1995 Jun; 115(2):255-62. PubMed ID: 7661884
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Quantitative assay of autoantibodies against low density lipoproteins].
    Khliustov VN
    Klin Lab Diagn; 1999 Apr; (4):17-20. PubMed ID: 10356899
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers.
    Virella G; Virella I; Leman RB; Pryor MB; Lopes-Virella MF
    Int J Clin Lab Res; 1993; 23(2):95-101. PubMed ID: 8518420
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL.
    Bergmark C; Wu R; de Faire U; Lefvert AK; Swedenborg J
    Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):441-5. PubMed ID: 7749854
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
    Khamis RY; Hughes AD; Caga-Anan M; Chang CL; Boyle JJ; Kojima C; Welsh P; Sattar N; Johns M; Sever P; Mayet J; Haskard DO
    EBioMedicine; 2016 Jul; 9():372-380. PubMed ID: 27333022
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C.
    Halevy D; Thiery J; Nagel D; Arnold S; Erdmann E; Höfling B; Cremer P; Seidel D
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1432-7. PubMed ID: 9261277
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Autoantibodies against oxidized low density lipoprotein: a review of clinical findings and assay methodology.
    Craig WY
    J Clin Lab Anal; 1995; 9(1):70-4. PubMed ID: 7722776
    [No Abstract]   [Full Text] [Related]  

  • 73. Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea.
    Saarelainen S; Lehtimäki T; Jaak-kola O; Poussa T; Nikkilä M; Solakivi T; Nieminen MM
    Clin Chem Lab Med; 1999 May; 37(5):517-20. PubMed ID: 10418741
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxidized LDL antibodies (OLAB) in patients with beta-thalassemia major.
    Brizzi P; Isaja T; D'Agata A; Malaguarnera L; Malaguarnera M; Musumeci S
    J Atheroscler Thromb; 2002; 9(3):139-44. PubMed ID: 12226555
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation and characterization of EIA measuring autoantibodies against oxidized LDL.
    Närvänen O; Erkkilä A; Ylä-Herttuala S
    Free Radic Biol Med; 2001 Sep; 31(6):769-77. PubMed ID: 11557315
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide.
    Fredrikson GN; Berglund G; Alm R; Nilsson JA; Shah PK; Nilsson J
    J Lipid Res; 2006 Sep; 47(9):2049-54. PubMed ID: 16809787
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Circulating immune complexes in 50-year-old men as a strong and independent risk factor for myocardial infarction.
    Mustafa A; Nityanand S; Berglund L; Lithell H; Lefvert AK
    Circulation; 2000 Nov; 102(21):2576-81. PubMed ID: 11085959
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Increased serum titers of autoantibodies against oxidized LDL cholesterol in young healthy adults.
    Karabinos I; Koulouris S
    Atherosclerosis; 2007 Jun; 192(2):448-50. PubMed ID: 17481638
    [No Abstract]   [Full Text] [Related]  

  • 79. LDL oxidation and coronary atherosclerosis.
    Schumacher M; Eber B; Tatzber F; Kaufmann P; Esterbauer H; Klein W
    Lancet; 1992 Jul; 340(8811):123. PubMed ID: 1351999
    [No Abstract]   [Full Text] [Related]  

  • 80. [Comparative analysis of the serum level of autoantibodies as a diagnostic tool of myocardial inflammatory diseases].
    Moiseeva OM; Mitrofanova LB; Nakatseva EV; Zverev DA; Skurydin SV; Poletaev AB
    Ter Arkh; 2012; 84(9):47-52. PubMed ID: 23091853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.